PWHL Professional Women's Hockey League

Professional Women's Hockey League Announces AIRSUPRA as First U.S. Founding Partner

February 28, 2024 - Professional Women's Hockey League (PWHL) News Release


TORONTO, ON - The Professional Women's Hockey League (PWHL)has announced today that AIRSUPRA© (albuterol/budesonide) Inhalation Aerosol is the league's first U.S. Founding Partner and will be the Official Pharmaceutical Brand of the PWHL in 2024.

AIRSUPRA© (albuterol/budesonide) Inhalation Aerosol, is a first-in-class, fixed-dose combination rescue medication to be taken as needed for the treatment or prevention of symptoms of asthma and to help prevent sudden severe breathing problems (asthma attacks) in people aged 18 years and older.

"We are proud to welcome AIRSUPRA to the PWHL community as our first Founding Partner in the United States," said sports icon and PWHL Advisory Board member Billie Jean King. "The support of AIRSUPRA underscores its belief in women's hockey and its commitment to our great league. We are looking forward to a truly fantastic relationship."

AIRSUPRA's partnership includes shoulder patches on jerseys of the league's three U.S. teams in Boston, Minnesota, and New York. AIRSUPRA will have multiple game activations and giveaways in U.S. markets throughout the season, along with in-arena signage, broadcast components, digital integration, and unique social media content across league and team platforms.

The inaugural PWHL regular season began on January 1, 2024, and includes 72 games through May 5, 2024, followed by playoffs.



Professional Women's Hockey League Stories from February 28, 2024


The opinions expressed in this release are those of the organization issuing it, and do not necessarily reflect the thoughts or opinions of OurSports Central or its staff.


Sports Statistics from the Stats Crew
OurSports Central